Phase 1 Pharmacokinetics, Safety, and Tolerability Study

NCT04067947 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

64

Enrollment

INDUSTRY

Sponsor class

Conditions

Pain

Interventions

DRUG: XG005
DRUG: Placebos

Sponsor

Xgene Pharmaceutical Group